Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
DRUG ATI001-102 A Phase I Study of Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Subjects with Recurrent or Progressive Glioblastoma or Grade III Malignant Glioma
Lesniak, Maciej S
(PD/PI)
Raizer, Jeffrey J
(PD/PI)
Neurological Surgery
Neurology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
10/29/14
→
4/30/22
Funding
ZIOPHARM Oncology, Inc.
(ATI001-102)
View all
View less